AVDL - Avadel Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue103,269173,245150,246173,009
Cost of Revenue17,51616,30147,85937,018
Gross Profit85,753156,944102,387135,991
Operating Expenses
Research Development39,32933,41833,41833,418
Selling General and Administrative100,35958,86044,17921,712
Non Recurring----
Others----
Total Operating Expenses163,823112,238105,92671,294
Operating Income or Loss-60,55461,00744,320101,715
Income from Continuing Operations
Total Other Income/Expenses Net-52,64331,653-54,038-24,010
Earnings Before Interest and Taxes-60,55461,00744,320101,715
Interest Expense-10,622-1,052-963-963
Income Before Tax-113,19792,660-9,71877,705
Income Tax Expense-17,89324,38931,55835,907
Minority Interest----
Net Income From Continuing Ops-95,30468,271-41,27641,798
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-95,30468,271-41,27641,798
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-95,30468,271-41,27641,798